Authors:
Weglage, J
Wiedermann, D
Denecke, J
Feldmann, R
Koch, HG
Ullrich, K
Harms, E
Moller, HE
Citation: J. Weglage et al., Individual blood-brain barrier phenylalanine transport determines clinicaloutcome in phenylketonuria, ANN NEUROL, 50(4), 2001, pp. 463-467
Authors:
Weglage, J
Pietsch, M
Feldmann, R
Koch, HG
Zschocke, J
Hoffmann, G
Muntau-Heger, A
Denecke, J
Guldberg, P
Guttler, F
Moller, H
Wendel, U
Ullrich, K
Harms, E
Citation: J. Weglage et al., Normal clinical outcome in untreated subjects with mild hyperphenylalaninemia, PEDIAT RES, 49(4), 2001, pp. 532-536
Authors:
Denecke, J
Schlegel, W
Koch, HG
Feldmann, R
Harms, E
Weglage, J
Citation: J. Denecke et al., Prolactin, a marker for cerebral dopamine deficiency in patients sufferingfrom phenylketonuria (PKU)?, J INH MET D, 23(8), 2000, pp. 849-NIL_1
Authors:
Weglage, J
Grenzebach, M
Pietsch, M
Feldmann, R
Linnenbank, R
Denecke, J
Koch, HG
Citation: J. Weglage et al., Behavioural and emotional problems in early-treated adolescents with phenylketonuria in comparison with diabetic patients and healthy controls, J INH MET D, 23(5), 2000, pp. 487-496
Authors:
Weglage, J
Pietsch, M
Sprinz, A
Feldmann, R
Denecke, J
Kurlemann, G
Citation: J. Weglage et al., A previously unpublished side effect of sulthiame in a patient with Rolandic epilepsy, NEUROPEDIAT, 30(1), 1999, pp. 50-50
Authors:
Weglage, J
Pietsch, M
Denecke, J
Sprinz, A
Feldmann, R
Grenzebach, M
Ullrich, K
Citation: J. Weglage et al., Regression of neuropsychological deficits in early-treated phenylketonurics during adolescence, J INH MET D, 22(6), 1999, pp. 693-705